Zhang, H;
Deng, M;
Lin, P;
Liu, J;
Liu, C;
Strohl, WR;
Wang, S;
(2018)
Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society.
Antibody Therapeutics
, 1
(2)
pp. 65-74.
10.1093/abt/tby009.
Preview |
Text
Zhang_Frontiers and Opportunities. Highlights of the 2nd Annual Conference of the Chinese Antibody Society_VoR.pdf - Published Version Download (14MB) | Preview |
Abstract
The Chinese Antibody Society (CAS) convened the second annual conference in Cambridge, MA, USA on 29 April 2018. More than 600 members from around the world attended the meeting. Invited speakers discussed the latest advancements in therapeutic antibodies with an emphasis on the progress made in China. The meeting covered a vast variety of topics including the current status of therapeutic antibodies, the progress of immuno-oncology, and biosimilars in China. The conference presentations also included the development of several novel antibodies such as antibodies related to weight loss, T-cell receptor-mimicking antibodies that target intracellular antigens, and tumor-targeting antibodies that utilize both innate and adaptive immune pathways. At the meeting, the CAS announced the launch of its official journal-Antibody Therapeutics-in collaboration with Oxford University Press. The conference was concluded by a panel discussion on how to bring a therapeutic drug developed in China to the USA for clinical trials.
| Type: | Article |
|---|---|
| Title: | Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/abt/tby009 |
| Publisher version: | https://doi.org/10.1093/abt/tby009 |
| Language: | English |
| Additional information: | © The Author(s) 2018. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| Keywords: | CAR T cells, Chinese Antibody Society, antibody therapeutics, biosimilars, bispecific antibodies |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10064452 |
Archive Staff Only
 |
View Item |
